Kim Sonya, Mortera Marianne H, Wen Pey-Shan, Thompson Karla L, Lundgren Kristine, Reed William R, Sasson Nicole, Towner Wright Sarah, Vora Ariana, Krishnan Shilpa, Joseph Justin, Heyn Patricia, Chin Bridget S
Departments of Rehabilitation Medicine (Drs Kim and Sasson) and Neurology (Dr Kim), New York University Grossman School of Medicine, New York; Department of Occupational Therapy, New York University, NYU Steinhardt, New York (Dr Mortera); Department of Occupational Therapy, Byrdine F. Lewis College of Nursing & Health Professions, Georgia State University, Atlanta, Georgia (Dr Wen); Department of Physical Medicine and Rehabilitation (Dr Thompson), University of North Carolina at Chapel Hill (Ms Wright); Department of Communication Sciences and Disorders, University of North Carolina Greensboro (Dr Lundgren); School of Health Professions, Department of Physical Therapy, University of Alabama at Birmingham (Dr Reed); Veterans Affairs New York Harbor Health Care System, New York (Dr Sasson); Spaulding Rehabilitation Network, Harvard Medical School, Boston, Massachusetts (Drs Vora and Chin); Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, Georgia (Dr Krishnan); Emory College of Arts and Sciences, Emory University, Atlanta, Georgia (Mr Joseph); Physical Medicine & Rehabilitation, University of Colorado at Denver, Anschutz Medical Campus (Dr Heyn); and College of Human Medicine, Michigan State University, Grand Rapids (Dr Chin).
J Head Trauma Rehabil. 2023;38(1):E33-E43. doi: 10.1097/HTR.0000000000000778. Epub 2022 Apr 21.
To examine the evidence levels, study characteristics, and outcomes of nonpharmacologic complementary and integrative medicine (CIM) interventions in rehabilitation for individuals with traumatic brain injury (TBI).
MEDLINE (OvidSP), PubMed (NLM), EMBASE ( Embase.com ), CINAHL (EBSCO), PsycINFO (OvidSP), Cochrane Library (Wiley), and National Guidelines Clearinghouse databases were evaluated using PRISMA guidelines. The protocol was registered in INPLASY (protocol registration: INPLASY202160071).
Quantitative studies published between 1992 and 2020 investigating the efficacy of CIM for individuals with TBI of any severity, age, and outcome were included. Special diets, herbal and dietary supplements, and counseling/psychological interventions were excluded, as were studies with mixed samples if TBI data could not be extracted. A 2-level review comprised title/abstract screening, followed by full-text assessment by 2 independent reviewers.
In total, 90 studies were included, with 57 001 patients in total. This total includes 2 retrospective studies with 17 475 and 37 045 patients. Of the 90 studies, 18 (20%) were randomized controlled trials (RCTs). The remainder included 20 quasi-experimental studies (2-group or 1-group pre/posttreatment comparison), 9 retrospective studies, 1 single-subject study design, 2 mixed-methods designs, and 40 case study/case reports. Guided by the American Academy of Neurology evidence levels, class II criteria were met by 61% of the RCTs. Included studies examined biofeedback/neurofeedback (40%), acupuncture (22%), yoga/tai chi (11%), meditation/mindfulness/relaxation (11%), and chiropractic/osteopathic manipulation (11%). The clinical outcomes evaluated across studies included physical impairments (62%), mental health (49%), cognitive impairments (39%), pain (31%), and activities of daily living/quality of life (28%). Additional descriptive statistics were summarized using narrative synthesis. Of the studies included for analyses, 97% reported overall positive benefits of CIM.
Rigorous and well experimentally designed studies (including RCTs) are needed to confirm the initial evidence supporting the use of CIM found in the existing literature.
探讨非药物补充与整合医学(CIM)干预对创伤性脑损伤(TBI)患者康复的证据水平、研究特征及结果。
使用PRISMA指南对MEDLINE(OvidSP)、PubMed(美国国立医学图书馆)、EMBASE(Embase.com)、CINAHL(EBSCO)、PsycINFO(OvidSP)、Cochrane图书馆(Wiley)和国家指南交换中心数据库进行评估。该方案已在INPLASY注册(方案注册号:INPLASY202160071)。
纳入1992年至2020年间发表的定量研究,这些研究调查了CIM对任何严重程度、年龄和结局的TBI患者的疗效。排除特殊饮食、草药和膳食补充剂以及咨询/心理干预,若无法提取TBI数据,也排除混合样本的研究。采用两级审查,先进行标题/摘要筛选,然后由两名独立评审员进行全文评估。
共纳入90项研究,总计57001例患者。这一总数包括两项回顾性研究,分别有17475例和37045例患者。在这90项研究中,18项(20%)为随机对照试验(RCT)。其余包括20项准实验研究(两组或一组治疗前后比较)、9项回顾性研究、1项单病例研究设计、2项混合方法设计以及40项病例研究/病例报告。以美国神经病学学会的证据水平为指导,61%的RCT符合II类标准。纳入的研究考察了生物反馈/神经反馈(40%)、针灸(22%)、瑜伽/太极拳(11%)、冥想/正念/放松(11%)以及整脊/骨病手法治疗(11%)。各项研究评估的临床结局包括身体损伤(62%)、心理健康(49%)、认知损伤(39%)、疼痛(31%)以及日常生活活动/生活质量(28%)。使用叙述性综合法总结了其他描述性统计数据。纳入分析的研究中,97%报告了CIM总体具有积极益处。
需要开展严谨且设计良好的实验性研究(包括RCT),以证实现有文献中支持使用CIM的初步证据。